This shareable PDF can be hosted on any platform or network and is fully compliant with publisher copyright.
This publication has not yet been explained in plain language by the author(s). However, you can still read the publication.
If you are one of the authors, claim this publication so you can create a plain language summary to help more people find, understand and use it.
This page is a summary of: Abstract CT074: Pre-existing ESR1 mutations in early-stage primary breast cancer predict failure of endocrine therapy and poor survival, Cancer Research, August 2020, American Association for Cancer Research (AACR),
DOI: 10.1158/1538-7445.am2020-ct074.
You can read the full text:
The following have contributed to this page
